Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway

Margaux Lecacheur,Ilona Berestjuk,Alexandrine Carminati,Oceane Bouvet,Serena Diazzi,Pierric Biber,Christopher Rovera,Marie Irondelle,Frederic Larbret,Virginie Prodhomme,Christophe A Girard,Marcel Deckert,Sophie Tartare-Deckert

DOI: https://doi.org/10.1101/2024.08.26.609700

2024-08-27

Abstract:Extracellular matrix (ECM) stiffening, resulting from increased collagen deposition and cross-linking, is a key biophysical factor of the tumor microenvironment. Cutaneous melanoma is a deadly metastatic cancer. Its aggressiveness stems from high intratumoral heterogeneity, resulting from the plasticity of melanoma cells, which transit from a melanocytic state to dedifferentiated therapy-resistant and invasive phenotypes, characterized by mesenchymal and/or neural crest stem cell-like features. Phenotypic plasticity is regulated by stroma-derived soluble factors, but the functional impact of ECM stiffening on melanoma cell phenotypes remains ill defined. Here, we found that melanoma cell subpopulations display difference in mechanical responsiveness. Compared to melanocytic cells, mesenchymal dedifferentiated cells showed increased proliferation, migration and resistance to MAP kinase-targeted therapy when seeded on stiff collagen. By contrast, a soft ECM impaired their proliferation and migration and sensitized them to targeted therapy. In addition, extracellular mechanical signals are required to sustain melanoma cell identity and dedifferentiation features. Further analyses indicated that the mechanosensitivity nature of dedifferentiated cells relies on the expression and activation of collagen receptors DDR1 and DDR2 that control actomyosin cytoskeleton reorganization and YAP mechanotransduction pathway. Inhibiting both DDR in dedifferentiated melanoma cells abrogated their mechano-induced behavior and drug-resistant phenotype, while forcing their expression in melanocytic cells induced mechanical responsiveness and a less differentiated phenotype. Our results reveal that phenotypic reprogramming endows dedifferentiated melanoma cells with increased sensitivity and addiction to ECM stiffness. We propose that mechano-addiction mediated by DDR collagen receptors may represent a novel vulnerability for aggressive dedifferentiated cancer cells that can be exploited for therapeutic benefits.

Cancer Biology

What problem does this paper attempt to address?

The problem this paper attempts to address is how the stiffness of the extracellular matrix (ECM) affects the phenotypic behavior of melanoma cells. Specifically, the paper explores the impact of ECM stiffness on the dedifferentiated melanoma cell phenotype through a discoidin domain receptor 1 and 2 (DDR1/2)-dependent YAP mechanotransduction pathway. The study found that, compared to melanocytes, mesenchymal-like dedifferentiated cells exhibit enhanced proliferation, migration capabilities, and resistance to targeted therapy on stiff collagen matrices. Additionally, soft ECM inhibited the proliferation and migration of these cells and made them more sensitive to targeted therapy. The paper also points out that ECM stiffness is crucial for maintaining the identity and dedifferentiated characteristics of melanoma cells, and this mechanosensitivity depends on the expression and activation of collagen receptors DDR1 and DDR2. In summary, the study reveals the high sensitivity and dependence of dedifferentiated melanoma cells on ECM stiffness and suggests that this could be a novel vulnerability that can be exploited to treat aggressive dedifferentiated cancer cells.